{"changes":[],"country":"ES","description":"Fastbase Solutions (HAWK Biosystems) developed a platform to discover and quantify novel disease biomarkers, including its QF-Pro assay. It targets immuno-oncology researchers and clinicians stratifying patients for treatment. Its differentiator is high-precision prediction of which patients will respond to immunotherapy.","domain":"fastbase-solutions.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"biotechnology","investors":[],"lat":43.263,"lng":-2.935,"location":"Biotechnology / Diagnostics","name":"FASTBASE SOLUTIONS","rounds":[{"amountQuarantined":false,"amountUsd":2635200,"currency":"EUR","date":"2024-02-28","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-08","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"fastbase-solutions-com","sources":[{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-08","status":"attributed","url":null},{"fact":"existence","publisher":"fastbase-solutions.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://fastbase-solutions.com"},{"fact":"description","publisher":"fastbase-solutions.com","retrievedAt":"2026-05-08","status":"self-reported","url":"https://fastbase-solutions.com"}],"stage":null,"techStack":[],"totalRaisedUsd":2876000,"updatedAt":"2026-05-08"}